CMS Open Payments · Program Year 2024
EnableCV Inc.
EnableCV Inc. reported $11,588.59 across General Payments, Research, and Ownership to 73 physicians and teaching hospitals across 73 transactions.
- $11.6K Below-median payer
- All-tracks total
- 73 Below-median volume
- Transactions
- 73 Below-median reach
- Recipients
- #1621
- of 1,925 companies
EnableCV Inc. reported $11,588.59 across all CMS Open Payments tracks (General + Research + Ownership) to 73 physicians and teaching hospitals in Program Year 2024 - ranking #1621 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $11,588.59, averaging $158.75 per recipient.
EnableCV Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
11/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer enablecv-inc EnableCV Inc.
$11.6K · #1621/1,925 · 0.0% industry · PY2024
- TOT $11.6K
- RANK #1621
- SHARE 0.0%
- TXN 73
- RCP 73
- CAT 2
- GEN $11.6K
- TOP1 10.4%
- PY 2024
Volume peers
Nearest volume peer: Greiner Bio-One North America, Inc. ($11.6K)
EnableCV Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for EnableCV Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For EnableCV Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $6.3K, accounting for 53.9% of this company's General Payments and 54 transactions.
General Payment Breakdown by Type
Across 2 types of general payments, EnableCV Inc.'s largest category was "Food and Beverage" at $6.3K - 53.9% of General Payments.
How EnableCV Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $6.3K | 54 | 53.9% |
| Travel and Lodging | $5.3K | 19 | 46.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $4,587.03 (39.6%) of $11,588.59 in this company's General Payments records across 39 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for EnableCV Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Clifton Thomas Lewis
$1,199.52 across 3 reported transactions
- 2
Danny Ramzy
$994.59 across 5 reported transactions
- 3
Douglas a Murphy
$833.32 across 3 reported transactions
- 4
Yuji Kawano
$833.32 across 3 reported transactions
- 5
Husam Balkhy
$726.28 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
EnableCV Inc.'s spend rank (#1621 of 1,925, bottom 16% by spend) and concentration rank (#1,279 of 1,838, bottom 30% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Catheter Precision Inc. : $1.3K total payments, HHI 525
- Centinel Spine, LLC : $742.0K total payments, HHI 525
- Roche Diagnostics International Ltd : $376.3K total payments, HHI 524
- Life Spine, Inc. : $327.4K total payments, HHI 523
- Sarepta Therapeutics, Inc. : $2.8M total payments, HHI 522
- Exeltis, USA Inc. : $704.0K total payments, HHI 519
- EnableCV Inc. (this company) : $11.6K total payments, HHI 517
- Ostial Corporation : $8.4K total payments, HHI 515
- 3Shape Inc : $19.3K total payments, HHI 512
- Lifeward, Inc. : $3.4K total payments, HHI 510
- Heron Therapeutics, Inc. : $907.0K total payments, HHI 510
- ITF Therapeutics LLC : $67.9K total payments, HHI 510
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as EnableCV Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about EnableCV Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with EnableCV Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Biobeat USA Inc.
Biolase MG LLC
Hoya Surgical Optics, Inc
Amnio Technology, LLC
Xenco Medical LLC
Put this to use
EnableCV Inc. ranks #1621 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just EnableCV Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.